Celularity (CELUW) Total Non-Current Liabilities (2019 - 2025)

Celularity (CELUW) reported Total Non-Current Liabilities of $143.8 million for Q4 2025, up 19.29% year-over-year from $120.6 million in Q4 2024, and up 9.97% quarter-over-quarter from $130.8 million in Q3 2025.

Celularity (CELUW) Total Non-Current Liabilities (2019 - 2025) Analysis & Trends

Celularity (CELUW) has 7 years of Total Non-Current Liabilities data on file, last reported at $143.8 million in Q4 2025.

  • Total Non-Current Liabilities for Q4 2025 came in at $143.8 million, up 19.29% year-over-year; the trailing twelve-month figure through Dec 2025 was $143.8 million (up 19.29% YoY), and the FY2025 annual result was $143.8 million, up 19.29% from the prior year.
  • Total Non-Current Liabilities advanced to $143.8 million in Q4 2025 per CELUW's latest filing, from $130.8 million in the prior quarter.
  • Over five years, Total Non-Current Liabilities peaked at $342.4 million in Q1 2022 and troughed at $16.0 million in Q1 2021.
  • A 5-year average of $134.7 million and a median of $123.0 million in 2023 frame the typical range for Total Non-Current Liabilities.
  • The sharpest annual moves came in 2022 and 2024: Total Non-Current Liabilities soared 2043.66% in 2022, then plunged 52.79% in 2024.
  • A 5-year view of Total Non-Current Liabilities shows it stood at $82.5 million in 2021, then gained by 16.65% to $96.2 million in 2022, then climbed by 6.67% to $102.6 million in 2023, then rose by 17.49% to $120.6 million in 2024, then climbed by 19.29% to $143.8 million in 2025.
  • Business Quant data shows CELUW's Total Non-Current Liabilities at $143.8 million in Q4 2025, $130.8 million in Q3 2025, and $137.0 million in Q2 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Non-Current Liabilities (Qtr)
1 Alterity Therapeutics 925,601.88 Bn 925,601.85 Bn - 42,980.09
2 Belite Bio 58,560.00 Bn 58,560.00 Bn - -
3 Quantum Biopharma 17,284.41 Bn 17,284.40 Bn - 11.03 Mn
4 Legend Biotech 2,809.00 Bn 2,808.71 Bn 242.10 Mn 95.20 Mn
5 Evaxion A 1,334.43 Bn 1,334.42 Bn - -
6 Akari Therapeutics 1,312.27 Bn 1,312.26 Bn - -
7 Psyence Biomedical 212.16 Bn 212.16 Bn - 644,700.00
8 Vertex Pharmaceuticals 114.83 Bn 107.58 Bn 2.59 Bn 5.87 Bn
9 Abivax 91.96 Bn 91.96 Bn - 64.76 Mn
10 Celularity - - -3.27 Mn 143.85 Mn

Historic Data

Download Data
DateValue
Dec 31, 2025 143.85 Mn
Sep 30, 2025 130.81 Mn
Jun 30, 2025 137.00 Mn
Mar 31, 2025 126.32 Mn
Dec 31, 2024 120.58 Mn
Sep 30, 2024 111.28 Mn
Jun 30, 2024 99.60 Mn
Mar 31, 2024 97.48 Mn
Dec 31, 2023 102.64 Mn
Sep 30, 2023 125.34 Mn
Jun 30, 2023 126.31 Mn
Mar 31, 2023 206.47 Mn
Dec 31, 2022 96.22 Mn
Sep 30, 2022 258.79 Mn
Jun 30, 2022 255.76 Mn
Mar 31, 2022 342.40 Mn
Dec 31, 2021 82.49 Mn
Sep 30, 2021 96.55 Mn
Jun 30, 2021 18.10 Mn
Mar 31, 2021 15.97 Mn